Genetic variability of the hepatitis C virus in the health area of Elche (Spain). Correlation between the core antigen and viral load;Variabilidad genética del virus de la hepatitis C en el área de salud de Elche. Correlación entre el antígeno del core y la carga viral

Gastroenterologia y Hepatologia

Volumn 26, Issue 7, 2003, Pages 407-410

  Rodriguez J C ^a   Garcia J ^a   Moya, I ^a   Ayelo, A ^a   Vazquez N ^a   Sillero, C ^a   Royo, G ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIGEN; HEPATITIS C CORE ANTIGEN; UNCLASSIFIED DRUG; VIRUS RNA;

ARTICLE; COMORBIDITY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; SPAIN; VIRUS DETECTION; VIRUS HEPATITIS; VIRUS LOAD;

EID: 0141682610     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13050352     Document Type: Article

References (26)

1. Cooreman MP, Schoondermark Van de Ven EM. Hepatitis C virus: biological and clinical consequences of genetic heterogenicity. Scand J Gastroenterol 1996;218:106-15.
2. Sánchez-Quijano A, Abad MA, Torronteras R, Rey C, Pineda JA, Leal M, et al. Unexpected high prevalence of hepatitis C virus genotype 4 in Southern Spain. J Hepatol 1997;27:25-9.
3. Cha TA, Beall B, Irvine J, Kolberg J, Chien D, Kuo G, et al. At least five related, but distinct, hepatitis C viral genotypes exist. Proc Natl Acad Sci USA 1992;89:7144-8.
4. León P, López JA, Amela C, Elola C, Echevarría JM. Prevalencia de tipos del virus de la hepatitis C en donantes de sangre españoles: resultados de un estudio multicéntrico de ámbito estatal. Grupo Español de Estudio de Donantes de Sangre en Riesgo de Transmisión del VHC. (GEDSRT-VHC). Enferm Infecc Microbiol Clin 1999;17:448-53.
5. López Labrador FX, Ampurdanes S, Forns X, Castells A, Sáiz JC, Costa J, et al. Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis ad hepatocellular carcinoma. J Hepatol 1997;27:959-65.
6. Elghouzzi MH, Bouchardeau F, Pillonel J, Boiret E, Tirtaine C, Barlet V, et al. Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors. Vox Sang 2000;79:138-44.
7. Pawlotsky JM, Taskiris L, Roudot-Thoraval F, Pellet C, Stuyver L, Duval J, et al. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. C J Infect Dis 1995;171:1607-10.
8. Pérez-Gracia T, Galán F, Fernández-Gutiérrez C, Girón JA, Rodríguez-Iglesias M. Relationship of hepatitis C viremia to HIV state and to infection by specific hepatitis C genotypes. Liver 1999;19:288-93.
9. Rubio M, Rubio C, Nogués A, Manonelles A. Genotipos del virus de la hepatitis C. Estudio de 302 pacientes coinfectados por el virus de la inmunodeficiencia humana. Med Clin (Barc) 2001; 116:650-1.
10. Bravo R, Soriano V, García-Samaniego J, González J, Castro A, Colmenero M. et al. Prevalencia de los genotipos del virus de la hepatitis C en drogadictos españoles con hepatitis crónica C. Grupo Español para el Estudio de las Hepatitis víricas en Pacientes VIH +. Rev Clin Esp 1996;196:673-7.
11. Blatt LM, Mutchnick MG, Tong MJ, Klion FM, Lebovics E, Freilich B, et al. Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States. J Viral Hepat 2000;7:196-202.
12. Smith DB, Davidson F, Yap P, Brown H, Kolberg J, Detmer J, et al. Levels of hepatitis C virus in blood donors infected with different viral genotypes. International HCV Collaborative Study Group. J Infect Dis 1996;173:727-30.
13. Lau JY, Davis GL, Prescott LE, Maertens G, Lindsay KL, Qian K, et al. Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group. Ann Intern Med 1996;124:868-76.
14. Bonacini M, Govindarajan S, Blatt LM, Schmid P, Conrad A, Lindsay KL, et al. Patients co-infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA. J Viral Hepat 1999;6:203-8.
15. Goedert JJ, Hatzakis A, Sherman KE, Eyster ME. Lack of association of hepatitis C virus load and genotype with risk of endstage liver disease in patients with human immunodeficiency virus coinfection. J Infect Dis 2001;184:1202-5.
16. Neau D, Trimoulet P, Winnock M, Le-Bail B, Schvoerer E, Legrand E, et al. Impact of protease inhibitors on intrahepatic hepatitis C virus viral load. AIDS 2001;15:1736-8.
17. Torre D, Tambini R, Cadario F, Barbarini C, Moroni M, Basilico C. Evolution of coinfection with human immunodeficiency virus and hepatitis C virus patients treated with highly antiretroviral therapy. Clin Infect Dis 2001;33:1579-85.
18. Aoyagi K, Ohue C, Iida K, Kimura T, Tanaka E, Kiyosawa K, et al. Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen. J Clin Microbiol 1999;37:1802-8.
19. Icardi G, Ansaldi F, Bruzzone BM, Durando P, Lee S, De Luigi C, et al. Novel approach to reduce the hepatitis C virus (HCV) window period: clinical evaluation of a new enzyme-linked immunosorbent assay for HCV core antigen. J Clin Microbiol 2001;39:3110-4.
20. Kurtz JB, Boxall E, Qusir N, Shirley J, Coleman D, Chandler C. The diagnostic significance of an assay for total hepatitis C core antigen. J Virol Methods 2001;96:127-32.
21. Tanaka E, Ohue C, Aoyagi K, Yamaguchi K, Yagi S, Kiyosawa K, et al. Evaluation of a new enzyme immunoassay for Hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA. Hepatology 2000;32:388-93.
22. Lagging LM, García CE, Westin J, Wejstal R, Norkrans G, Dhillon AP, et al. Comparison of serum hepatitis C virus RNA and core antigen concentrations and determination of whether levels are associated with liver histology or affected by specimen storage time. J Clin Microbiol 2002;40:4224-9.
23. Bouvier-Alias M, Patel K, Dahari H, Beaucourt S, Larderie P, Blatt L, et al. Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. Hepatology 2002;36:211-8.
24. Mellor J, Hawkins A, Simmonds P. Genotype dependence of hepatitis C virus load measurement in commercially available quantitative assays. J Clin Microbiol 1999;37:2525-32.
25. Pawlotsky JM. Use and interpretation of virological tests for hepatitis C. Hepatology 2002;36(Suppl 1):S65-73.
26. Lunel F, Veillon P, Payan C. Hepatitis C virus RNA and HCV core antigen kinetics predict the efficiency of alfa-interferon and ribavirin therapy in naive patients infected by hepatitis c virus genotype 2 or 3 [abstract V-235]. 42nd ICAAC Abstract. American Society for Microbiology, September 27-30, San Diego, p. 426.